Qingdao Vland Biotech INC
SSE:603739
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aegis Vopak Terminals Ltd
NSE:AEGISVOPAK
|
IN |
Qingdao Vland Biotech INC
Capital Expenditures
Qingdao Vland Biotech INC
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Qingdao Vland Biotech INC
SSE:603739
|
Capital Expenditures
-¥85.4m
|
CAGR 3-Years
39%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Capital Expenditures
-¥3.4B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-41%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Capital Expenditures
-¥1.2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
RemeGen Co Ltd
SSE:688331
|
Capital Expenditures
-¥200m
|
CAGR 3-Years
36%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
Akeso Inc
HKEX:9926
|
Capital Expenditures
-¥793m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
|
Capital Expenditures
-¥126.3m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Qingdao Vland Biotech INC
Glance View
Qingdao Vland Biotech Co., Ltd. manufactures biotech products. The company is headquartered in Qingdao, Shandong and currently employs 1,534 full-time employees. The company went IPO on 2019-01-16. The firm's main products are enzyme preparations, micro-ecology and animal health products, such as feed enzymes, industrial enzymes, food enzymes, plant micro-ecological preparations, veterinary chemicals and veterinary drugs. The firm's products are mainly used in the washing, textile, food, feed, paper, energy and pharmaceutical industries. The firm mainly distributes its products in China and overseas markets.
See Also
What is Qingdao Vland Biotech INC's Capital Expenditures?
Capital Expenditures
-85.4m
CNY
Based on the financial report for Sep 30, 2025, Qingdao Vland Biotech INC's Capital Expenditures amounts to -85.4m CNY.
What is Qingdao Vland Biotech INC's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
16%
Over the last year, the Capital Expenditures growth was 53%. The average annual Capital Expenditures growth rates for Qingdao Vland Biotech INC have been 39% over the past three years , 16% over the past five years .
